Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Current Deferred Revenue (2020 - 2021)

BioAtla (BCAB) has 2 years of Current Deferred Revenue data on record, last reported at $19.8 million in Q3 2021.

  • For Q3 2021, Current Deferred Revenue changed N/A year-over-year to $19.8 million; the TTM value through Sep 2021 reached $19.8 million, changed N/A, while the annual FY2020 figure was $19.8 million, N/A changed from the prior year.
  • Current Deferred Revenue reached $19.8 million in Q3 2021 per BCAB's latest filing, roughly flat from $19.8 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $19.8 million in Q4 2020 and bottomed at $393000.0 in Q1 2021.